Anti-growth Effects of Imatinib and GNF5 via Regulation of Skp2 in Human Hepatocellular Carcinoma Cells

Mostrar otras versiones (1)

BACKGROUND: Human hepatocellular carcinoma (HCC) is a common liver tumor and the main cause of cancer-related death. Tyrosine kinase inhibitors, such as imatinib and GNF5 which were developed to treat chronic myelogenous leukemia, regulate the progression of various cancers. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Hyun, Kim, Myoung-Ok, Kim, Ki-Rim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330986/
https://www.ncbi.nlm.nih.gov/pubmed/30671399
http://dx.doi.org/10.15430/JCP.2018.23.4.170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330986/
https://www.ncbi.nlm.nih.gov/pubmed/30671399
http://dx.doi.org/10.15430/JCP.2018.23.4.170

Ejemplares similares